RxDoctor Payments Data

John Debello, DPM

Podiatrist · Bronx, NYNPI 1568402576

Payments from drug & device makers

$4,320in general payments, 2019–2025

Across 120 payments — averaging $36.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mimedx Group, Inc.$2K
  • Amgen$492
  • Paratek Pharmaceuticals, Inc.$438
  • Arthrex$288
  • Gotham Surgical Solutions & Devices, Inc.$286
  • Merck$233
  • plus $942 from 17 others

What the payments were for

  • Travel & lodging$1,25429%
  • Food & beverage$3,06771%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,320 in reported general payments places this provider in the 85th percentile of 862 podiatrist providers in New York.

See all podiatrist providers in New York

Medicare billing

Part B allowed, 2024
$91,043
Medicare patients
291
Services billed
1,799

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate736$389,948
Doxepin Hcl463$344,965
JubliaEfinaconazole224$193,349
Diclofenac Sodium540$189,041
LofenaDiclofenac Potassium18$132,381
ErtaczoSertaconazole Nitrate85$113,329
Chlorpromazine Hcl141$111,756
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc354$97,173
Budesonide ErBudesonide121$92,389
Diflorasone Diacetate96$68,910
CiclopiroxCiclopirox Olamine1,245$65,562
Diclofenac Potassium11$59,387
Naproxen Sodium ErNaproxen Sodium33$47,613
Fluocinonide120$43,664
Naftifine Hcl59$28,794

Paid to pharmacies, not to this prescriber.

Other podiatrist in Bronx

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →